Samuel C. Blackman, HEAD OF R&D at Day One Biopharmaceuticals, Inc. (DAWN), sold 2,206 shares at $13.21 ($29K) on 2024-11-18, disclosed to the SEC on 2024-11-19.
Open-market sale of $29k DAWN by HEAD OF R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |
| DAWN | SELL | 2024-09-12 | $427K | — | Filing → |